UCSF research led to the first type 1 diabetes immunotherapy. Now, scientists are using stem cells and Tregs to find a ...

The latest type 2 diabetes (T2D) management guidance from the American Association of Clinical Endocrinology (AACE) covers ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

The National Institutes of Health has provided $3.5 million for a large-scale clinical trial testing a radical new approach to managing type 2 diabetes that, in an earlier study, put almost 70% of ...

The QBSAFE agenda-setting kit (ASK) is a novel patient-centric approach to diabetes care that has feasible study procedures and is well accepted by patients with type 2 diabetes and their clinicians.

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with custom-engineered immune cells that protect them. The goal is to stop the immune system ...

INDIANAPOLIS — A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an ...

Contemporary Approach to Neurofibromatosis Type 1–Associated Malignant Peripheral Nerve Sheath Tumors. If you have the appropriate software installed, you can download article citation data to the ...